De novo mutations in schizophrenia implicate synaptic networks

Sullivan, P. F., Daly, M. J. & O’Donovan, M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nature Rev. Genet. 13, 537–551 (2012)

Bundy, H., Stahl, D. & MacCabe, J. H. A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr. Scand. 123, 98–106 (2011)

McClellan, J. M., Susser, E. & King, M.-C. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190, 194–199 (2007)

Malhotra, D. & Sebat, J. Genetics: Fish heads and human disease. Nature 485, 318–319 (2012)

Rees, E., Moskvina, V., Owen, M. J., O’Donovan, M. C. & Kirov, G. De novo rates and selection of schizophrenia-associated copy number variants. Biol. Psychiatry 70, 1109–1114 (2011)

Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012)

O’Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246–250 (2012)

Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012)

Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285–299 (2012)

Rauch, A. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380, 1674–1682 (2012)

de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921–1929 (2012)

Girard, S. L. et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nature Genet. 43, 860–863 (2011)

Xu, B. et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nature Genet. 44, 1365–1369 (2012)

Gulsuner, S. et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154, 518–529 (2013)

Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature http://dx.doi.org/10.1038/nature12975 (22 January 2014)

Kong, A. et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature 488, 471–475 (2012)

Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P. & Faraone, S. V & Seidman, L. J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23, 315–336 (2009)

Glessner, J. T. et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl Acad. Sci. USA 107, 10584–10589 (2010)

Malhotra, D. et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72, 951–963 (2011)

Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142–153 (2012)

Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011)

Malenka, R. C. & Nicoll, R. A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16, 521–527 (1993)

Bramham, C. R. et al. The Arc of synaptic memory. Exp. Brain Res. 200, 125–140 (2010)

Korb, E. & Finkbeiner, S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci. 34, 591–598 (2011)

Shepherd, J. D. & Bear, M. F. New views of Arc, a master regulator of synaptic plasticity. Nature Neurosci. 14, 279–284 (2011)

Mikuni, T. et al. Arc/Arg3.1 Is a postsynaptic mediator of activity-dependent synapse elimination in the developing cerebellum. Neuron 78, 1024–1035 (2013)

Feinberg, I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatr. Res. 17, 319–334 (1982)

Darnell, J. C. & Klann, E. The translation of translational control by FMRP: therapeutic targets for FXS. Nature Neurosci. 16, 1530–1536 (2013)

Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genet. 25 25–29 (2000)

Gilman, S. R. et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898–907 (2011)

Golzio, C. et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 485, 363–367 (2012)

Steinberg, S. et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum. Mol. Genet. 20, 4076–4081 (2011)

von Eichborn, J. et al. SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations. Nucleic Acids Res. 41, D834–D840 (2013)

Aoto, J., Martinelli, D. C., Malenka, R. C., Tabuchi, K. & Südhof, T. C. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 154, 75–88 (2013)

Williams, N. M. et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376, 1401–1408 (2010)

Girirajan, S. et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N. Engl. J. Med. 367, 1321–1331 (2012)

Owen, M. J., O’Donovan, M. C., Thapar, A. & Craddock, N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 198, 173–175 (2011)

Nozawa, R.-S. et al. Human POGZ modulates dissociation of HP1α from mitotic chromosome arms through Aurora B activation. Nature Cell Biol. 12, 719–727 (2010)

Buxbaum, J. D. et al. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 76, 1052–1056 (2012)

Craddock, N. & Owen, M. J. The Kraepelinian dichotomy – going, going...but still not gone. Br. J. Psychiatry 196, 92–95 (2010)

Insel, T. R. Transforming diagnosis. NIMH Director’s Blog http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml (29 April 2013)

Pocklington, A. J., Armstrong, J. D. & Grant, S. G. N. Organization of brain complexity–synapse proteome form and function. Brief. Funct. Genomics Proteomics 5, 66–73 (2006)

Coba, M. P. et al. TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. J. Neurosci. 32, 13987–13999 (2012)

Ruderfer, D. M. et al. A family-based study of common polygenic variation and risk of schizophrenia. Mol. Psychiatry 16, 887–888 (2011)